PharmaVoice Logo

Healthcare Leaders Hub

Insights+: An Analysis of the Growth of Biopharma Companies in the Last 20 Years (2006-2025) 

PharmaShots

Insights+: An Analysis of the Growth of Biopharma Companies in the Last 20 Years (2006-2025) 

Shots:  The two decades from 2006 to 2025 reflect one of the most transformative periods in biopharma history, characterized by scientific breakthroughs, strategic consolidation, and remarkable commercial growth. The industry successfully navigated patent expirations, global economic downturns, biosimilar competition, pricing reforms, and the unprecedented COVID-19 pandemic while continuing to deliver innovative therapies. Mergers and acquisitions… The post Insights+: An Analysis of the Growth of Biopharma Companies in the Last 20 Years (2006-2025)  appeared first on PharmaShots.

Read Full Article
Bayer banks €3bn in Apollo contraceptives division deal

Pharma Tech

Bayer banks €3bn in Apollo contraceptives division deal

Bayer's agreement with Apollo comes a little after Bayer broke its pharma dealmaking fast by acquiring Perfuse Therapeutics in May 2026.

Read Full Article
Chinese biotech MindRank secures $52m to advance AI-designed oral GLP-1RA

Pharma Tech

Chinese biotech MindRank secures $52m to advance AI-designed oral GLP-1RA

The funds will support the progression of MindRank’s pipeline, which is heavily dominated by obesity indications.

Read Full Article
Ipsen set to rival Botox after duo of Phase III migraine wins

Pharma Tech

Ipsen set to rival Botox after duo of Phase III migraine wins

Ipsen claims that Dysport has become the first botulinum toxin therapy to demonstrate efficacy in episodic migraine.

Read Full Article
Teva and Polpharma Biologics sign global deal for ocrelizumab biosimilar

Pharma Tech

Teva and Polpharma Biologics sign global deal for ocrelizumab biosimilar

Teva Pharmaceuticals International and Polpharma Biologics have signed a global licensing agreement for a proposed biosimilar to Ocrevus to treat multiple sclerosis.

Read Full Article

Sponsored content

Featured promotional

Jeplus.in
Sponsored

Jeplus.in

Purchase All Medicines.Get 10% Offer

News

Latest stories

PharmaShots

Jul 10, 2026, 1:30 PM

Insights+: An Analysis of the Growth of Biopharma Companies in the Last 20 Years (2006-2025) 

Shots:  The two decades from 2006 to 2025 reflect one of the most transformative periods in biopharma history, characterized by scientific breakthroughs, strategic consolidation, and remarkable commercial growth. The industry successfully navigated patent expirations, global economic downturns, biosimilar competition, pricing reforms, and the unprecedented COVID-19 pandemic while continuing to deliver innovative therapies. Mergers and acquisitions… The post Insights+: An Analysis of the Growth of Biopharma Companies in the Last 20 Years (2006-2025)  appeared first on PharmaShots.

Pharma Tech

Jul 10, 2026, 1:11 PM

Bayer banks €3bn in Apollo contraceptives division deal

Bayer's agreement with Apollo comes a little after Bayer broke its pharma dealmaking fast by acquiring Perfuse Therapeutics in May 2026.

PharmaShots

Jul 10, 2026, 12:30 PM

Hansoh Reports P-III (ARTEMIS-008) Trial Data on Risvutatug Rezetecan for Advanced or Relapsed SCLC

Shots: Ref: Hansoh |  Image: Hansoh  | Press Release Related News: Hansoh Pharmaceutical Reports the EC Approval of Aumseqa for Non-small Cell Lung Cancer (NSCLC)  PharmaShots, your go-to media platform for customized news ranging across multiple indications. For more information, connect with us at connect@pharmashots.com The post Hansoh Reports P-III (ARTEMIS-008) Trial Data on Risvutatug Rezetecan for Advanced or Relapsed SCLC appeared first on PharmaShots.

PharmaShots

Jul 10, 2026, 11:30 AM

Viz.ai Partners with Cortechs.ai to Expand AI Platform into Neurodegenerative Disease Care

Shots: Ref: Businesswire |  Image:  Viz.ai & Cortechs.ai  | Press Release Related News: Viz.ai Enters a Multi-Year Partnership with Sanofi and Regeneron to Improve Management and Care of COPD PharmaShots, your go-to media platform for customized news ranging across multiple indications. For more information, connect with us at connect@pharmashots.com The post Viz.ai Partners with Cortechs.ai to Expand AI Platform into Neurodegenerative Disease Care appeared first on PharmaShots.

ET Pharma

Jul 10, 2026, 11:11 AM

Bayer gets €3 billion in Apollo deal for contraceptives unit

Apollo funds and affiliates would take a minority, non-controlling stake in a new entity holding the LARC business, while Bayer keeps a majority stake and "complete operational control."

Pharma Tech

Jul 10, 2026, 10:46 AM

Chinese biotech MindRank secures $52m to advance AI-designed oral GLP-1RA

The funds will support the progression of MindRank’s pipeline, which is heavily dominated by obesity indications.

News

Latest industry coverage

Google News

Jul 10, 2026, 8:46 PM

Navi Mumbai On It's Way To Boost Pharma Trade - BW Businessworld

Navi Mumbai On It's Way To Boost Pharma Trade  BW Businessworld

Google News

Jul 10, 2026, 8:18 PM

Apnimed, Sleep Apnea Drug Developer, Files for Nasdaq Global Market IPO - TradingView

Apnimed, Sleep Apnea Drug Developer, Files for Nasdaq Global Market IPO  TradingView

Google News

Jul 10, 2026, 8:16 PM

FDA’s rule seeks to modernize drug manufacturing registration - PharmaLive

FDA’s rule seeks to modernize drug manufacturing registration  PharmaLive

Google News

Jul 10, 2026, 8:12 PM

German lawmakers approve healthcare shake-up aimed at taming costs - Reuters

German lawmakers approve healthcare shake-up aimed at taming costs  Reuters

Google News

Jul 10, 2026, 7:11 PM

West Pharmaceutical Services (WST) Sells SmartDose Rights To AbbVie To Refocus Its Business - Yahoo Finance UK

West Pharmaceutical Services (WST) Sells SmartDose Rights To AbbVie To Refocus Its Business  Yahoo Finance UK

Google News

Jul 10, 2026, 6:56 PM

Teva (TEVA) Stock Looks Reasonable Even With A 48% Gap - simplywall.st

Teva (TEVA) Stock Looks Reasonable Even With A 48% Gap  simplywall.st

Google News

Jul 10, 2026, 5:49 PM

US FDA approves Sanofi's wearable injector form of blood cancer drug - Reuters

US FDA approves Sanofi's wearable injector form of blood cancer drug  Reuters

Google News

Jul 10, 2026, 5:27 PM

Trace-Level Testing, Validation Pressure, and the New Demands on Pharma Labs - Lab Manager

Trace-Level Testing, Validation Pressure, and the New Demands on Pharma Labs  Lab Manager

Google News

Jul 10, 2026, 5:13 PM

The FDA Moves to Modernize Drug Manufacturing Registration - PharmTech.com

The FDA Moves to Modernize Drug Manufacturing Registration  PharmTech.com

Sponsored placement

Featured promotions

Jeplus.in
Sponsored

Jeplus.in

Purchase All Medicines.Get 10% Offer